Medco Health Solutions Inc., the largest U.S. pharmacy benefits management company, spent $600,000 in the second quarter of the fiscal year as it lobbied the federal government on health care reform legislation and other issues, according to Bloomberg Businessweek.
Medco said it discussed issues including the health care reform law, economic stimulus funding for electronic health records, generic versions of biologic drugs, comparative effectiveness research on similar drugs, privacy and security rules, the Medicare Part D drug benefit, antitrust laws, and prescription drug importation.
The company said it lobbied Congress, the Centers for Medicare and Medicaid Services, the Food and Drug Administration, the Department of Health and Human Services, the White House, and the Federal Trade Commission. It disclosed its lobbying in a form filed July 20 with the House clerk’s office.
The Franklin Lakes, N.J., company reduced its lobbying spending by 14 percent compared to a year ago. In the second quarter of 2009 it spent $697,000 on lobbying and in $960,000 in the 2010 first quarter.